Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2015

01-06-2015 | Letter to the Editor

Trends in the Management of Headache

Authors: John N. Mafi, MD, Samuel T. Edwards, MD, Nigel P. Pedersen, MB, BS, Bruce E. Landon, MD, MBA, MSc

Published in: Journal of General Internal Medicine | Issue 6/2015

Login to get access

Excerpt

The Authors’ Reply—We thank Dr. Solomon for his interest in our study assessing national trends in headache management and for raising important questions about the usefulness of lifestyle modification counseling. As noted, we found a decline in first-line recommended lifestyle modification counseling for headache over the past decade, contrary to prominent headache guidelines.1 For instance, guidelines from the American College of Physicians suggest that physicians encourage their patients to identify and avoid specific dietary, behavioral, and environmental triggers for migraine headache.2
Literature
1.
go back to reference Mafi JN, Edwards ST, Pedersen NP, Davis RB, McCarthy EP, Landon BE. Trends in the Ambulatory Management of Headache: Analysis of NAMCS and NHAMCS Data 1999–2010. J Gen Intern Med. 2015;1–8. doi:10.1007/s11606-014-3107-3 Mafi JN, Edwards ST, Pedersen NP, Davis RB, McCarthy EP, Landon BE. Trends in the Ambulatory Management of Headache: Analysis of NAMCS and NHAMCS Data 1999–2010. J Gen Intern Med. 2015;1–8. doi:10.​1007/​s11606-014-3107-3
2.
go back to reference Snow V, Weiss K, Wall EM. Guidelines for the treatment and prevention of migraine headaches. Ann Intern Med. 2002;137(10):840–852.CrossRefPubMed Snow V, Weiss K, Wall EM. Guidelines for the treatment and prevention of migraine headaches. Ann Intern Med. 2002;137(10):840–852.CrossRefPubMed
3.
go back to reference Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1366–1370.CrossRefPubMed Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1366–1370.CrossRefPubMed
4.
go back to reference Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V. Behavioral and physical treatments for migraine headache. Technical Review 2.2. 1999. (Prepared for the Agency for Health Care Policy and Research under contract no. 29009402025. Available from the National Technical Information Service; NTIS accession no. 127946.) Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V. Behavioral and physical treatments for migraine headache. Technical Review 2.2. 1999. (Prepared for the Agency for Health Care Policy and Research under contract no. 29009402025. Available from the National Technical Information Service; NTIS accession no. 127946.)
5.
go back to reference Holroyd KA, Cottrell CK, O’Donnell FJ, et al. Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871.CrossRefPubMedCentralPubMed Holroyd KA, Cottrell CK, O’Donnell FJ, et al. Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010;341:c4871.CrossRefPubMedCentralPubMed
Metadata
Title
Trends in the Management of Headache
Authors
John N. Mafi, MD
Samuel T. Edwards, MD
Nigel P. Pedersen, MB, BS
Bruce E. Landon, MD, MBA, MSc
Publication date
01-06-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3223-8

Other articles of this Issue 6/2015

Journal of General Internal Medicine 6/2015 Go to the issue

Clinical Practice: Clinical Images

Everything Points to Myeloma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.